These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16546214)

  • 61. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.
    Umhau JC; Schwandt ML; Usala J; Geyer C; Singley E; George DT; Heilig M
    Neuropsychopharmacology; 2011 May; 36(6):1178-86. PubMed ID: 21289601
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.
    Kiefer F; Witt SH; Frank J; Richter A; Treutlein J; Lemenager T; Nöthen MM; Cichon S; Batra A; Berner M; Wodarz N; Zimmermann US; Spanagel R; Wiedemann K; Smolka MN; Heinz A; Rietschel M; Mann K
    Pharmacogenomics J; 2011 Oct; 11(5):368-74. PubMed ID: 20585342
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents.
    Niederhofer H; Staffen W
    Drug Alcohol Rev; 2003 Sep; 22(3):295-7. PubMed ID: 15385223
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):55-8. PubMed ID: 9845038
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
    Kampman KM; Dackis C; Pettinati HM; Lynch KG; Sparkman T; O'Brien CP
    Addict Behav; 2011 Mar; 36(3):217-21. PubMed ID: 21112155
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acamprosate: a new pharmacotherapeutic approach to relapse prevention in alcoholism--preliminary data.
    Soyka M; Sass H
    Alcohol Alcohol Suppl; 1994; 2():531-6. PubMed ID: 8974379
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
    Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
    Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of community nurse follow-up when treating alcohol dependence with acamprosate.
    Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P
    Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
    Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
    Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.
    Mason BJ; Crean R
    Expert Rev Neurother; 2007 Nov; 7(11):1465-77. PubMed ID: 17997696
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.
    Ooteman W; Koeter MW; Verheul R; Schippers GM; van den Brink W
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):558-66. PubMed ID: 17379484
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.
    Sass H; Soyka M; Mann K; Zieglgänsberger W
    Arch Gen Psychiatry; 1996 Aug; 53(8):673-80. PubMed ID: 8694680
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    Expert Opin Drug Saf; 2010 Jan; 9(1):177-88. PubMed ID: 20021295
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.
    Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A;
    Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():55-8. PubMed ID: 8737001
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study.
    Langosch JM; Spiegelhalder K; Jahnke K; Feige B; Regen W; Kiemen A; Hennig J; Olbrich HM
    J Clin Psychopharmacol; 2012 Oct; 32(5):661-5. PubMed ID: 22926600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.
    Tolliver BK; Desantis SM; Brown DG; Prisciandaro JJ; Brady KT
    Bipolar Disord; 2012 Feb; 14(1):54-63. PubMed ID: 22329472
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acamprosate for alcohol dependence.
    Rösner S; Hackl-Herrwerth A; Leucht S; Lehert P; Vecchi S; Soyka M
    Cochrane Database Syst Rev; 2010 Sep; (9):CD004332. PubMed ID: 20824837
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acamprosate and primitive reflexes.
    Guzik P; Bankes L; Brown TM
    Ann Pharmacother; 2007 Apr; 41(4):715-8. PubMed ID: 17389668
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
    Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A
    Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.